{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:20:46Z","timestamp":1759936846840,"version":"3.41.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T00:00:00Z","timestamp":1444694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T00:00:00Z","timestamp":1444694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1038\/gt.2015.100","type":"journal-article","created":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T15:14:41Z","timestamp":1444749281000},"page":"151-157","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Liquid jet delivery method featuring S100A1 gene therapy in the rodent model following acute myocardial infarction"],"prefix":"10.1038","volume":"23","author":[{"given":"A S","family":"Fargnoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M G","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R D","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A P","family":"Kendle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Steuerwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C R","family":"Bridges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,13]]},"reference":[{"key":"BFgt2015100_CR1","doi-asserted-by":"publisher","first-page":"13889","DOI":"10.1073\/pnas.241393598","volume":"98","author":"P Most","year":"2001","unstructured":"Most P, Bernotat J, Ehlermann P, Pleger ST, Reppel M, B\u00f6rries M et al. S100A1: a regulator of cardiac contractility. Proc Natl Acad Sci USA 2001; 98: 13889\u201313894.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt2015100_CR2","doi-asserted-by":"publisher","first-page":"R568","DOI":"10.1152\/ajpregu.00075.2007","volume":"293","author":"P Most","year":"2007","unstructured":"Most P, Remppis A, Pleger ST, Katus HA, Koch WJ . S100A1: a novel inotropic regulator of cardiac performance. Transition from molecular physiology to pathophysiological relevance. Am J Physiol Regul Integr Comp Physiol 2007; 293: R568\u2013R577.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"BFgt2015100_CR3","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1161\/CIRCULATIONAHA.106.671701","volume":"115","author":"ST Pleger","year":"2007","unstructured":"Pleger ST, Most P, Boucher M, Soltys S, Chuprun JK, Pleger W et al. Stable myocardial-specific AAV-S100A1 gene therapy results in chronic functional heart failure rescue. Circulation 2007; 115: 2506\u20132515.","journal-title":"Circulation"},{"key":"BFgt2015100_CR4","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1128\/MCB.02045-06","volume":"27","author":"M Boerries","year":"2007","unstructured":"Boerries M, Most P, Gledhill JR, Walker JE, Katus HA, Koch WJ et al. Ca2+-dependent interaction of S100A1 with F1-ATPase leads to an increased ATP content in cardiomyocytes. Mol Cell Biol 2007; 27: 4365\u20134373.","journal-title":"Mol Cell Biol"},{"key":"BFgt2015100_CR5","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1016\/S0006-3495(01)75876-6","volume":"81","author":"R Yamasaki","year":"2001","unstructured":"Yamasaki R, Berri M, Wu Y, Trombit\u00e1s K, McNabb M, Kellermayer MS et al. Titin-actin interaction in mouse myocardium: passive tension modulation and its regulation by calcium\/S100A1. Biophys J 2001; 81: 2297\u20132313.","journal-title":"Biophys J"},{"key":"BFgt2015100_CR6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.33549\/physiolres.930109","volume":"50","author":"B Maco","year":"2001","unstructured":"Maco B, Mandinova A, Durrenberger MB, Schafer BW, Uhrik B, Heizmann CW . Ultrastructural distribution of the S100A1 Ca2+-binding protein in the human heart. Physiol Res 2001; 50: 567\u2013574.","journal-title":"Physiol Res"},{"key":"BFgt2015100_CR7","doi-asserted-by":"publisher","first-page":"33809","DOI":"10.1074\/jbc.M301788200","volume":"5","author":"P Most","year":"2003","unstructured":"Most P, Remppis A, Pleger ST, Loffler E, Ehlermann P, Bernotat J et al. Transgenic overexpression of the Ca2+ binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance. J Biol Chem 2003; 5: 33809\u201333817.","journal-title":"J Biol Chem"},{"key":"BFgt2015100_CR8","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1161\/CIRCULATIONAHA.106.622415","volume":"114","author":"P Most","year":"2006","unstructured":"Most P, Seifert H, Gao E, Funakoshi H, Volkers M, Heierhorst J et al. Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction. Circulation 2006; 114: 1258\u20131268.","journal-title":"Circulation"},{"key":"BFgt2015100_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4155\/tde.13.134","volume":"5","author":"MG Katz","year":"2014","unstructured":"Katz MG, Fargnoli AS, Williams RD, Bridges CR . The road ahead: working toward effective clinical translation of myocardial gene therapies. Ther Deliv 2014; 5: 39\u201351.","journal-title":"Ther Deliv"},{"key":"BFgt2015100_CR10","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.cardfail.2011.03.011","volume":"17","author":"AS Fargnoli","year":"2011","unstructured":"Fargnoli AS, Katz MG, Yarnall C, Sumaroka MV, Stedman H, Rabinowitz JJ et al. A pharmacokinetic analysis of molecular cardiac surgery with recirculation mediated delivery of \u03b2ARKct gene therapy: developing a quantitative definition of the therapeutic window. J Card Fail 2011; 17: 691\u2013699.","journal-title":"J Card Fail"},{"key":"BFgt2015100_CR11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1089\/hum.2012.241","volume":"24","author":"MG Katz","year":"2013","unstructured":"Katz MG, Fargnoli AS, Bridges CR . Myocardial gene transfer: routes and devices for regulation of transgene expression by modulation of cellular permeability. Hum Gene Ther 2013; 24: 375\u2013392.","journal-title":"Hum Gene Ther"},{"key":"BFgt2015100_CR12","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.yjmcc.2010.09.003","volume":"50","author":"MG Katz","year":"2011","unstructured":"Katz MG, Swain JD, Tomasulo CE, Sumaroka M, Fargnoli AS, Bridges CR . Current strategies for myocardial gene delivery. J Mol Cell Cardiol 2011; 50: 766\u2013776.","journal-title":"J Mol Cell Cardiol"},{"key":"BFgt2015100_CR13","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1089\/hum.2013.2517","volume":"24","author":"MG Katz","year":"2013","unstructured":"Katz MG, Fargnoli AS, Williams RD, Bridges CR . Gene therapy delivery systems for enhancing viral and nonviral vectors for cardiac diseases: current concepts and future applications. Hum Gene Ther 2013; 24: 914\u2013927.","journal-title":"Hum Gene Ther"},{"key":"BFgt2015100_CR14","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1161\/01.CIR.100.5.468","volume":"100","author":"TK Rosengart","year":"1999","unstructured":"Rosengart TK, Lee LY, Patel SR, Sanborn TA, Parikh M, Bergman GW et al. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 1999; 100: 468\u2013474.","journal-title":"Circulation"},{"key":"BFgt2015100_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cardfail.2009.01.013","volume":"15","author":"BE Jaski","year":"2009","unstructured":"Jaski BE, Jessup ML, Mancini DM, Cappola TP, Pauly DF, Greenberg B et al. Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1\/2 clinical trial. J Card Fail 2009; 15: 171\u2013181.","journal-title":"J Card Fail"},{"key":"BFgt2015100_CR16","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.111.022889","volume":"124","author":"M Jessup","year":"2011","unstructured":"Jessup M, Greenberg B, Mancini D, Cappola T, Pauly DF, Jaski B et al. Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure. Circulation 2011; 124: 304\u2013313.","journal-title":"Circulation"},{"key":"BFgt2015100_CR17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cardfail.2008.02.005","volume":"14","author":"RJ Hajjar","year":"2008","unstructured":"Hajjar RJ, Zsebo K, Deckelbaum L, Thompson C, Rudy J, Yaroshinsky A et al. Design of a phase 1\/2 trial of intracoronary administration of AAV1\/SERCA2a in patients with heart failure. J Card Fail 2008; 14: 355\u2013367.","journal-title":"J Card Fail"},{"key":"BFgt2015100_CR18","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1007\/s12265-014-9593-1","volume":"7","author":"AS Fargnoli","year":"2014","unstructured":"Fargnoli AS, Katz MG, Williams RD, Margulies KB, Bridges CR . A needleless liquid jet injection delivery method for cardiac gene therapy: a comparative evaluation versus standard routes of delivery reveals enhanced therapeutic retention and cardiac specific gene expression. J Cardiovasc Transl Res 2014; 7: 756\u2013767.","journal-title":"J Cardiovasc Transl Res"},{"key":"BFgt2015100_CR19","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1038\/sj.gt.3302134","volume":"10","author":"DM McCarty","year":"2003","unstructured":"McCarty DM, Fu H, Monahan PE, Toulson CE, Naik P, Samulski RJ . Adeno-associated virus terminal repeat mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo. Gene Therapy 2003; 10: 2112\u20132118.","journal-title":"Gene Therapy"},{"key":"BFgt2015100_CR20","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1128\/jvi.70.5.3227-3234.1996","volume":"70","author":"FK Ferrari","year":"1996","unstructured":"Ferrari FK, Samulski T, Shenk T, Samulski RJ . Second-strand synthesis is a rate limiting step for efficient transduction by recombinant adeno-associated virus vectors. J Virol 1996; 70: 3227\u20133234.","journal-title":"J Virol"},{"key":"BFgt2015100_CR21","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1128\/jvi.70.1.520-532.1996","volume":"70","author":"KJ Fisher","year":"1996","unstructured":"Fisher KJ, Gao GP, Weitzman MD, DeMatteo R, Burda JF, Wilson JM . Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J Virol 1996; 70: 520\u2013532.","journal-title":"J Virol"},{"key":"BFgt2015100_CR22","doi-asserted-by":"publisher","first-page":"13104","DOI":"10.1073\/pnas.0702778104","volume":"104","author":"J Wang","year":"2007","unstructured":"Wang J, Xie J, Lu H, Chen L, Hauck B, Samulski RJ et al. Existence of transient functional double-stranded DNA intermediates during recombinant AAV transduction. Proc Natl Acad Sci USA 2007; 104: 13104\u201313109.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt2015100_CR23","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/mt.2008.15","volume":"16","author":"DD Koeberl","year":"2008","unstructured":"Koeberl DD, Pinto C, Sun B, Li S, Kozink DM, Benjamin DK Jr et al. AAV vector-mediated reversal of hypoglycemia in canine and murine glycogen storage disease type Ia. Mol Ther 2008; 16: 665\u2013672.","journal-title":"Mol Ther"},{"key":"BFgt2015100_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1479-0556-5-13","volume":"5","author":"LM Andino","year":"2007","unstructured":"Andino LM, Conlon TJ, Porvasnik SL, Boye SL, Hauswirth WW, Lewin AS . Rapid, widespread transduction of the murine myocardium using self-complementary adeno-associated virus. Genet Vaccines Ther 2007; 5: 13.","journal-title":"Genet Vaccines Ther"},{"key":"BFgt2015100_CR25","doi-asserted-by":"crossref","unstructured":"Wu J, Zhao W, Zhong L, Han L, Li B, Ma W et al. Self-complementary recombinant adeno-associated viral vectors: packaging capacity and the role of rep proteins in vector purity. Hum Gene Ther 18: 171\u2013182.","DOI":"10.1089\/hum.2006.088"},{"key":"BFgt2015100_CR26","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/978-1-62703-230-8_25","volume":"963","author":"P Most","year":"2013","unstructured":"Most P, Raake P, Weber C, Katus HA, Pleger ST . S100A1 gene therapy in small and large animals. Methods Mol Biol 2013; 963: 407\u2013420.","journal-title":"Methods Mol Biol"},{"key":"BFgt2015100_CR27","doi-asserted-by":"publisher","first-page":"92ra64","DOI":"10.1126\/scitranslmed.3002097","volume":"3","author":"ST Pleger","year":"2011","unstructured":"Pleger ST, Shan C, Ksienzyk J, Bekeredjian R, Boekstegers P, Hinkel R et al. Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model. Sci Transl Med 2011; 3: 92ra64.","journal-title":"Sci Transl Med"},{"key":"BFgt2015100_CR28","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ymthe.2004.07.016","volume":"10","author":"MJ Blankinship","year":"2004","unstructured":"Blankinship MJ, Gregorevic P, Allen JM, Harper SQ, Harper H, Halbert CL et al. Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6. Mol Ther 2004; 10: 671\u2013678.","journal-title":"Mol Ther"},{"key":"BFgt2015100_CR29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nbt1073","volume":"3","author":"Z Wang","year":"2005","unstructured":"Wang Z, Zhu T, Qiao C, Zhou L, Wang B, Zhang J et al. Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat Biotechnol 2005; 3: 321\u2013328.","journal-title":"Nat Biotechnol"},{"key":"BFgt2015100_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/mt.2010.250","volume":"1","author":"LE Mays","year":"2011","unstructured":"Mays LE, Wilson JM . The complex and evolving story of T cell activation to AAV vector-encoded transgene products. Mol Ther 2011; 1: 16\u201327.","journal-title":"Mol Ther"},{"key":"BFgt2015100_CR31","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1161\/01.CIR.81.4.1161","volume":"81","author":"MA Pfeffer","year":"1990","unstructured":"Pfeffer MA, Braunwald E . Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990; 81: 1161\u20131172.","journal-title":"Circulation"},{"key":"BFgt2015100_CR32","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/gt.2013.63","volume":"21","author":"C Weber","year":"2014","unstructured":"Weber C, Neacsu I, Krautz B, Schlegel P, Sauer S, Raake P et al. Therapeutic safety of high myocardial expression levels of the molecular inotrope S100A1 in a preclinical heart failure model. Gene Therapy 2014; 21: 131\u2013138.","journal-title":"Gene Therapy"},{"key":"BFgt2015100_CR33","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/gt.2008.120","volume":"15","author":"MJ Byrne","year":"2008","unstructured":"Byrne MJ, Power JM, Preovolos A, Mariani JA, Hajjar RJ, Kaye DM . Recirculating cardiac delivery of AAV2\/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals. Gene Therapy 2008; 15: 1550\u20131557.","journal-title":"Gene Therapy"},{"key":"BFgt2015100_CR34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jacc.2007.03.047","volume":"50","author":"DM Kaye","year":"2007","unstructured":"Kaye DM, Preovolos A, Marshall T, Byrne M, Hoshijima M, Hajjar R et al. Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals. J Am Coll Cardiol 2007; 50: 253\u2013260.","journal-title":"J Am Coll Cardiol"},{"key":"BFgt2015100_CR35","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/gt.2009.35","volume":"16","author":"CR Bridges","year":"2009","unstructured":"Bridges CR . 'Recirculating cardiac delivery' method of gene delivery should be called 'non-recirculating' method. Gene Therapy 2009; 16: 939\u2013940.","journal-title":"Gene Therapy"},{"key":"BFgt2015100_CR36","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/gt.2014.47","volume":"21","author":"Q Liu","year":"2014","unstructured":"Liu Q, Huang W, Zhang H, Wang Y, Zhao J, Song A et al. Neutralizing antibodies against AAV2, AAV5 and AAV8 in healthy and HIV-1-infected subjects in China: implications for gene therapy using AAV vectors. Gene Therapy 2014; 21: 732\u2013738.","journal-title":"Gene Therapy"},{"key":"BFgt2015100_CR37","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/978-0-387-34814-8_12","volume":"590","author":"S Partid\u00e1-S\u00e1nchez","year":"2007","unstructured":"Partid\u00e1-S\u00e1nchez S, Rivero-Nava L, Shi G, Lund FE . CD38: an ecto-enzyme at the crossroads of innate and adaptive immune responses. Adv Exp Med Biol 2007; 590: 171\u2013183.","journal-title":"Adv Exp Med Biol"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt2015100.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt2015100","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt2015100.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:46:07Z","timestamp":1748652367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt2015100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,13]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["BFgt2015100"],"URL":"https:\/\/doi.org\/10.1038\/gt.2015.100","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"type":"print","value":"0969-7128"},{"type":"electronic","value":"1476-5462"}],"subject":[],"published":{"date-parts":[[2015,10,13]]},"assertion":[{"value":"15 June 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}